AQW-051
Tier C — Watch / tradeAQW-051
Targets：nAChRα7
Indications (approved)：Anxiety, 表现焦虑, Alzheimer's disease, Mild cognitive impairment, Schizophrenia, 运动障碍
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| AQW-051 | 669770-29-0 | - |
| AQW-051-001 | 1072-98-6 | 5-chloropyridin-2-amine |
| AQW-051-002 | 40473-01-6 | 2-bromo-5-chloropyridine |
| AQW-051-003 | 5720-05-8 | p-tolylboronic acid |
| AQW-051-004 | 669770-63-2 | 5-chloro-2-(p-tolyl)pyridine |
| AQW-051-005 | 25333-42-0 | (R)-quinuclidin-3-ol |
Frequently asked questions
What are the approved indications of AQW-051?
Approved indications include: Anxiety, 表现焦虑, Alzheimer's disease, Mild cognitive impairment, Schizophrenia, 运动障碍.
When does the AQW-051 patent expire?
No public expiry year is available for AQW-051 yet; this page updates once verified.
How many synthesis routes are recorded for AQW-051?
1 synthesis routes are recorded; the shortest is 3 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy AQW-051 intermediates?
All intermediates in AQW-051 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for AQW-051 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30